TherapeuticsMD Inc (TXMD) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows no significant positive momentum, lacks recent news or catalysts, and has a weak price trend. Additionally, there are no proprietary trading signals indicating a strong buy opportunity.
The technical indicators show mixed signals. The MACD is slightly positive but contracting, RSI is neutral at 37.75, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock's price has dropped significantly (-14.10% in the regular market) and is hovering near its key support level (S1: 1.85).

NULL identified. No recent news or events suggest a positive catalyst for the stock.
The stock has experienced a significant regular market drop (-14.10%), and there is no recent news or insider/hedge fund activity to support a recovery. Additionally, the stock is projected to decline (-7.81%) over the next month based on candlestick pattern analysis.
No financial data available for the latest quarter, making it difficult to assess the company's growth trends.
No recent analyst ratings or price target changes available.
